These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30792104)

  • 1. Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline.
    Blaser A; Sutherland HS; Tong AST; Choi PJ; Conole D; Franzblau SG; Cooper CB; Upton AM; Lotlikar M; Denny WA; Palmer BD
    Bioorg Med Chem; 2019 Apr; 27(7):1283-1291. PubMed ID: 30792104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel.
    Sutherland HS; Tong AST; Choi PJ; Blaser A; Conole D; Franzblau SG; Lotlikar MU; Cooper CB; Upton AM; Denny WA; Palmer BD
    Bioorg Med Chem; 2019 Apr; 27(7):1292-1307. PubMed ID: 30803745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles.
    Sutherland HS; Tong AST; Choi PJ; Conole D; Blaser A; Franzblau SG; Cooper CB; Upton AM; Lotlikar MU; Denny WA; Palmer BD
    Bioorg Med Chem; 2018 May; 26(8):1797-1809. PubMed ID: 29482950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in the C-unit of bedaquiline provides analogues with improved biology and pharmacology.
    Sutherland HS; Tong AST; Choi PJ; Blaser A; Franzblau SG; Cooper CB; Upton AM; Lotlikar M; Denny WA; Palmer BD
    Bioorg Med Chem; 2020 Jan; 28(1):115213. PubMed ID: 31810890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units.
    Choi PJ; Sutherland HS; Tong AST; Blaser A; Franzblau SG; Cooper CB; Lotlikar MU; Upton AM; Guillemont J; Motte M; Queguiner L; Andries K; Van den Broeck W; Denny WA; Palmer BD
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5190-5196. PubMed ID: 29107541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents based on Bedaquiline Structure.
    Wu C; Luo J; Wu M; Meng F; Cai Z; Chen Y; Sun T
    Med Chem; 2020; 16(5):703-714. PubMed ID: 31203803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Anti-tubercular Analogues of Bedaquiline with Modified A-, B- and C-Ring Subunits.
    Barbaro L; Nagalingam G; Triccas JA; Tan L; West NP; Priebbenow DL; Baell JB
    ChemMedChem; 2023 Jan; 18(1):e202200533. PubMed ID: 36259365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876-A Less Toxic and More Potent Analogue of Bedaquiline.
    Choi PJ; Conole D; Sutherland HS; Blaser A; Tong AST; Cooper CB; Upton AM; Palmer BD; Denny WA
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32245020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds.
    He C; Preiss L; Wang B; Fu L; Wen H; Zhang X; Cui H; Meier T; Yin D
    ChemMedChem; 2017 Jan; 12(2):106-119. PubMed ID: 27792278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis.
    Tong AST; Choi PJ; Blaser A; Sutherland HS; Tsang SKY; Guillemont J; Motte M; Cooper CB; Andries K; Van den Broeck W; Franzblau SG; Upton AM; Denny WA; Palmer BD; Conole D
    ACS Med Chem Lett; 2017 Oct; 8(10):1019-1024. PubMed ID: 29057044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Perspective of ATP Synthase Inhibitors in the Management of the Tuberculosis.
    Divita KM; Khatik GL
    Curr Top Med Chem; 2021; 21(18):1623-1643. PubMed ID: 34517802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis.
    Sutherland HS; Lu GL; Tong AST; Conole D; Franzblau SG; Upton AM; Lotlikar MU; Cooper CB; Palmer BD; Choi PJ; Denny WA
    Eur J Med Chem; 2022 Feb; 229():114059. PubMed ID: 34963068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bedaquiline: a new hope to treat multi-drug resistant tuberculosis.
    Patel RV; Riyaz SD; Park SW
    Curr Top Med Chem; 2014; 14(16):1866-74. PubMed ID: 25262806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic approaches towards bedaquiline and its derivatives.
    Calvert MB; Furkert DP; Cooper CB; Brimble MA
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127172. PubMed ID: 32291133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.
    Gupta S; Cohen KA; Winglee K; Maiga M; Diarra B; Bishai WR
    Antimicrob Agents Chemother; 2014; 58(1):574-6. PubMed ID: 24126586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of
    Sarathy JP; Ragunathan P; Shin J; Cooper CB; Upton AM; Grüber G; Dick T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    Worley MV; Estrada SJ
    Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents.
    Kang S; Kim YM; Jeon H; Park S; Seo MJ; Lee S; Park D; Nam J; Lee S; Nam K; Kim S; Kim J
    Eur J Med Chem; 2017 Aug; 136():420-427. PubMed ID: 28527405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
    Lopez B; Siqueira de Oliveira R; Pinhata JMW; Chimara E; Pacheco Ascencio E; Puyén Guerra ZM; Wainmayer I; Simboli N; Del Granado M; Palomino JC; Ritacco V; Martin A
    J Antimicrob Chemother; 2019 Feb; 74(2):373-379. PubMed ID: 30358851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis.
    Lu GL; Tong AST; Conole D; Sutherland HS; Choi PJ; Franzblau SG; Upton AM; Lotlikar MU; Cooper CB; Denny WA; Palmer BD
    Bioorg Med Chem; 2020 Nov; 28(22):115784. PubMed ID: 33007562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.